OpenVSafe by OpenVAERS
Search V-safe

9G3-17649-19015

4 vaccinations 8 coded responses 32 check-ins 8 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
871 / NM
Registered
2021-02-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-03
    Dose 1 — Moderna
  2. 2021-02-04
    Registered in v-safe
  3. 2021-02-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Nausea, Rash, not including the immediate area around the injection site
    Adult check-in
  5. 2021-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  6. 2021-02-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  8. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  9. 2021-02-10
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Redness, Swelling, Itching · None
    Adult check-in
  10. 2021-02-17
    Survey response — day 14, dose 1
    MedDRA: Injection site urticaria, Peripheral swelling, Pruritus — Feeling: Good
    Free text: Severe erythema extending length of entire deltoid. Moderate swelling of deltoid. Severe itching over area. Small wheel at actual injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-24
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-03
    Dose 2 — Moderna
  13. 2021-03-17
    Survey response — day 14, dose 2
    MedDRA: Asthenia, Fatigue, Headache, Nausea, Pain, Pyrexia — Feeling: Good · Be unable to do your normal daily activities
    Free text: Mild fever, fatigue, body aches, weakness, nausea, headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-07
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-14
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-02
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-09-01
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-12-29
    Dose 3 — Moderna
  21. 2022-03-03
    Survey response — 12 months, dose 2
    MedDRA: Cough, SARS-CoV-2 test negative — Feeling: Good
    Free text: Chronic cough after negative antigen covid test (PCR not run)
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-11-08
    Dose 4 — Pfizer-BioNTech
  23. 2022-11-08
    Health check-in — day 0, dose 4
    Feeling: Fair · Site: Pain, Swelling · None
    Adult check-in
  24. 2022-11-09
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  25. 2022-11-10
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Rash, not including the immediate area around the injection site
    Free text: Severe lymphadenopathy of supraclavicular and axillary lymph nodes
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-11-11
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Moderate to severe lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-11-12
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Swelling · Headache · Be unable to do your normal daily activities
    Free text: Moderate lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-11-13
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Headache
    Free text: Mild lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-11-14
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Swelling · Headache
    Adult check-in
  30. 2022-11-15
    Health check-in — day 7, dose 4
    Feeling: Good · Joint pains
    Adult check-in
  31. 2022-11-22
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  32. 2022-11-29
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  33. 2022-12-06
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-12-13
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-12-20
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  36. 2023-02-07
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  37. 2023-05-09
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-03Moderna
22021-03-03Moderna
32021-12-29Moderna No
42022-11-08Pfizer-BioNTech No

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-04

Systemic reaction (other): Dizziness

Release 4 — day 14, dose 1

2021-02-17

Symptoms: Severe erythema extending length of entire deltoid. Moderate swelling of deltoid. Severe itching over area. Small wheel at actual injection site.

Release 5 — day 14, dose 2

2021-03-17

Symptoms: Mild fever, fatigue, body aches, weakness, nausea, headache

Release 11 — 12 months, dose 2

2022-03-03

Symptoms: Chronic cough after negative antigen covid test (PCR not run)

Release 12 — days 1–6 daily, dose 4

2022-11-10

Systemic reaction (other): Severe lymphadenopathy of supraclavicular and axillary lymph nodes

2022-11-11

Systemic reaction (other): Moderate to severe lymphadenopathy

2022-11-12

Systemic reaction (other): Moderate lymphadenopathy

2022-11-13

Systemic reaction (other): Mild lymphadenopathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia ✓ ✓ ✓
SDCough · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDInjection site urticaria ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPeripheral swelling ✓ ✓ ✓
SDPruritus ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDSARS-CoV-2 test negative · · ✓
SRODizziness ✓ ✓ ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release